Riferimento farmaci
Lunsotogene parvec
Lunsotogene parvec is a medicine in the class miscellaneous.
- Classe del farmaco: Miscellaneous
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Miscellaneous
- Forme farmaceutiche comuni
- iniezione
- Nomi commerciali
- 1
- Paesi e mercati
- 1
Come agisce
Intracochlear infusion results in expression of the OTOF gene primarily in inner hair cells, which facilitates production of functional otoferlin protein and restores synaptic transmission to the auditory nerve (shown in mouse studies).
Dose abituale nell'adulto (sintesi del foglio illustrativo)
OTOF-associated severe-to-profound sensorineural hearing loss: 7.2 × 10 12 vector genomes (vg) per ear in a total volume of 0.24 mL, single-dose intracochlear infusion; bilateral treatment given in a single surgical session
Gravidanza e allattamento
- Gravidanza
- Unknown Gene therapy given once by infusion into the inner ear for OTOF-related deafness. No data in pregnancy and no animal reproduction studies. Confirm a negative pregnancy test before treatment in women who could become pregnant.
- Allattamento
- Unknown No data on passage into milk, effects on the breastfed infant or milk production. Most patients are children; for an adult mother, discuss with the treating team before breastfeeding.
Effetti indesiderati segnalati
- Otitis media
- Vomiting
- Nausea
- Dizziness
- Procedural pain
- Gait disturbance
Chi deve prestare attenzione
- Procedure-related adverse reactions may occur, including vertigo, tinnitus, CSF leak, facial paresis, taste change, meningitis, wound infection, mastoiditis, numbness around the ear, and labyrinthitis; monitor and manage
- Not recommended when preoperative imaging shows inner ear access is not feasible (e.g., abnormal mastoid pneumatization or anatomic variations)
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Lunsotogene parvec: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Lunsotogene parvec used for?
Lunsotogene parvec is a medicine in the class miscellaneous.
What side effects have been reported with Lunsotogene parvec?
Otitis media, Vomiting, Nausea, Dizziness, Procedural pain, Gait disturbance.
Can Lunsotogene parvec be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Gene therapy given once by infusion into the inner ear for OTOF-related deafness. No data in pregnancy and no animal reproduction studies. Confirm a negative pregnancy test before treatment in women who could become pregnant. Breastfeeding: Unknown. No data on passage into milk, effects on the breastfed infant or milk production. Most patients are children; for an adult mother, discuss with the treating team before breastfeeding.
What does Lunsotogene parvec interact with?
MediHelp does not list a checked interaction for Lunsotogene parvec yet. Always tell your pharmacist about every medicine you take.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
